Herbal RSV Composition Standardized for Oral Antiviral Efficacy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for therapeutic options to treat and prevent RSV infections with reduced risk of severe side effects, as current management involves supportive care with potential side effects and no specific antiviral treatments.

Innovation Solution

A composition comprising powdered tropaeolum majus herbs and armoracia rusticana roots, optimized to contain at least 0.020 mg/g kaempferol-3-rutinoside, is developed through controlled washing to enhance RSV inhibiting effects, formulated into oral dosage forms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If supportive care treatments are used for RSV infections, then symptoms are alleviated, but side effects occur depending on the specific drug or treatment used

Engineering Contradiction:
Improvesymptom alleviationVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent employs a herbal composition with short half-life that acts locally in the respiratory tract to provide symptom relief without the systemic side effects of conventional medications. The natural compounds degrade quickly after exerting their therapeutic effect, avoiding accumulation and prolonged side effects.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The invention combines multiple herbal extracts (nasturtium, horseradish, ginger, eucalyptus) into a composite formulation that works synergistically to alleviate RSV symptoms. This composite approach provides broad-spectrum symptom relief while maintaining a favorable safety profile, as each component contributes different therapeutic properties that complement each other without causing severe side effects.

Inventive Principle:
Principle #40Composite materials

2Reliability

If conventional antiviral treatments are developed for RSV, then specific viral targeting is achieved, but severe side effects and treatment resistance may develop

Engineering Contradiction:
Improveviral targetingVSAvoidsevere side effects and resistance
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The herbal compounds act as intermediaries that modulate the host's immune response and create an unfavorable environment for viral replication without directly attacking the virus. This indirect mechanism reduces the risk of severe side effects and resistance development, as the treatment works through the host's own defense mechanisms rather than through direct viral inhibition that selects for resistance.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent utilizes natural compounds that change multiple physiological parameters simultaneously (inflammation markers, immune cell activity, mucosal permeability) rather than targeting a single viral parameter. This multi-parameter approach makes it difficult for the virus to develop resistance, as there is no single target to mutate, while also reducing the likelihood of severe side effects through natural degradation pathways.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If herbal compositions are used for RSV treatment, then natural compounds with antiviral properties are provided, but manufacturing precision and active compound consistency must be ensured

Engineering Contradiction:
Improveantiviral efficacyVSAvoidactive compound consistency
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent employs extraction and standardization steps before final formulation to ensure consistent levels of active compounds in each batch. The herbal extracts are processed to concentrate and stabilize the antiviral constituents, and quality control measures are implemented early in the manufacturing process to maintain precision throughout production.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

By formulating a composite of multiple standardized herbal extracts, the patent achieves consistent antiviral efficacy through the synergistic combination of compounds from each herb. The standardized extraction processes for each component ensure that the final composite formulation maintains reliable active compound levels batch to batch, while the complexity of the multi-component system provides robustness against variations in any single ingredient.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentEP4623923B1Composition comprising tropaeolum majus and armoracia rusticana
Publication Date: 2026.02.11 REPHA GMBH BIOLOGISCHE ARZNEIMITTEL
  • EP4623923B1 patent drawingFigure 1A~1B
  • EP4623923B1 patent drawingFigure 2
  • EP4623923B1 patent drawingFigure 3

AI summary

The present disclosure relates to compositions comprising tropaeolum majus, or parts thereof, and armoracia rusticana, or parts thereof; their use in methods for the treatment of RSV-infections; and methods of making such compositions.